Worldwide Cancer Vaccines Industry to 2026 - Featuring AstraZeneca, GlaxoSmithKline and Moderna Among Others - ResearchAndMarkets.com
Furthermore, numerous studies are being conducted in the field of viral recombinant cancer vaccines, which may reap positive results in future, primarily related to cancer vaccination.
- Furthermore, numerous studies are being conducted in the field of viral recombinant cancer vaccines, which may reap positive results in future, primarily related to cancer vaccination.
- The National Cancer Institute (NCI) stated that the national spending on cancer care is expected to reach USD 156 billion by 2020.
- Providence Therapeutics is a Toronto based clinical stage biotechnology company that develops cancer vaccines for human use.
- Currently company is developing a personalized mRNA cancer vaccine designed to generate strong T cell responses that aim to kill cancer cells and destroy tumors in ovarian cancer, breast cancer and brain cancer.